Search research articles
Contact Us
Filters
Showing results (81-90 of 316) with videos related to
Page
of 32
Sort By:
BMC Research Notes
|
March 18, 2010
A review of data needed to parameterize a dynamic model of measles in developing countries
Emily K Szusz, Louis P Garrison, Chris T Bauch
American Industrial Hygiene Association Journal
|
July 1, 1991
Development of a field method for determining the service lives of respirator cartridges--Part IV: Results of field validation trials
H J Cohen, S P Levine, R P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2019
Defining and Managing High-Priced Cures: Healthcare Payers' Opinions
Kai Yeung, Kangho Suh, Louis P Garrison, et al.
Value in Health Regional Issues
|
December 12, 2018
Value-Based Pricing in Latin America: How Far Away Are We?
Aurelio Mejía, Ramiro Gilardino, Finn Børlum Kristensen, et al.
The Journal of Urology
|
April 8, 2014
Resource utilization and costs associated with the diagnostic evaluation of nonrefluxing primary hydronephrosis in infants
Ardavan Akhavan, Margarett Shnorhavorian, Louis P Garrison, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 21, 2012
The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literature
Russell Becker, Carole Dembek, Leigh Ann White, et al.
Journal of Comparative Effectiveness Research
|
September 10, 2024
Why is the market design for innovative pharmaceuticals not well understood?
Francisco Olivença, Jose Diaz, Sreeram V Ramagopalan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2024
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework
Boshen Jiao, Josh J Carlson, Louis P Garrison, et al.
Pharmacoeconomics
|
April 12, 2006
Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK
Beate Sander, Frederick G Hayden, Marlene Gyldmark, et al.
Journal of Medical Economics
|
April 28, 2018
Heart rate variability testing: could it change spending for rheumatoid arthritis patients in the United States? An exploratory economic analysis
Marita Zimmermann, Elisabeth Vodicka, Andrew J Holman, et al.
Page
of 32
Search research articles
Search
Showing results (81-90 of 316) with videos related to
Sort By:
Page
of 32
BMC Research Notes
|
March 18, 2010
A review of data needed to parameterize a dynamic model of measles in developing countries
Emily K Szusz, Louis P Garrison, Chris T Bauch
American Industrial Hygiene Association Journal
|
July 1, 1991
Development of a field method for determining the service lives of respirator cartridges--Part IV: Results of field validation trials
H J Cohen, S P Levine, R P Garrison
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2019
Defining and Managing High-Priced Cures: Healthcare Payers' Opinions
Kai Yeung, Kangho Suh, Louis P Garrison, et al.
Value in Health Regional Issues
|
December 12, 2018
Value-Based Pricing in Latin America: How Far Away Are We?
Aurelio Mejía, Ramiro Gilardino, Finn Børlum Kristensen, et al.
The Journal of Urology
|
April 8, 2014
Resource utilization and costs associated with the diagnostic evaluation of nonrefluxing primary hydronephrosis in infants
Ardavan Akhavan, Margarett Shnorhavorian, Louis P Garrison, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 21, 2012
The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literature
Russell Becker, Carole Dembek, Leigh Ann White, et al.
Journal of Comparative Effectiveness Research
|
September 10, 2024
Why is the market design for innovative pharmaceuticals not well understood?
Francisco Olivença, Jose Diaz, Sreeram V Ramagopalan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 8, 2024
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework
Boshen Jiao, Josh J Carlson, Louis P Garrison, et al.
Pharmacoeconomics
|
April 12, 2006
Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK
Beate Sander, Frederick G Hayden, Marlene Gyldmark, et al.
Journal of Medical Economics
|
April 28, 2018
Heart rate variability testing: could it change spending for rheumatoid arthritis patients in the United States? An exploratory economic analysis
Marita Zimmermann, Elisabeth Vodicka, Andrew J Holman, et al.
Page
of 32